Results of BCG adjuvant immunotherapy for melanoma of the head and neck

Frederick R. Eilber, Courtney Townsend, Donald L. Morton

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The present study was performed to determine if postoperative systemic BCG adjuvant immunotherapy would improve survival in patients with pathologic stage II melanoma of the head and neck. Seventeen of twenty-five (68 per cent) patients treated with BCG are free of disease, whereas only seven of seventeen (40 per cent) patients treated by radical neck dissection alone are free of disease. Clark's technic for determining the level of invasion of the primary lesion was used to predict the presence of metastatic tumor in regional lymph nodes. Results indicate that patients with pathologically confirmed lymph node metastases from melanoma of the head and neck benefit from postoperative BCG adjuvant immunotherapy.

Original languageEnglish (US)
Pages (from-to)476-479
Number of pages4
JournalThe American Journal of Surgery
Volume132
Issue number4
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Mycobacterium bovis
Immunotherapy
Melanoma
Neck
Head
Lymph Nodes
Neck Dissection
Neoplasm Metastasis
Survival
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Results of BCG adjuvant immunotherapy for melanoma of the head and neck. / Eilber, Frederick R.; Townsend, Courtney; Morton, Donald L.

In: The American Journal of Surgery, Vol. 132, No. 4, 1976, p. 476-479.

Research output: Contribution to journalArticle

Eilber, Frederick R. ; Townsend, Courtney ; Morton, Donald L. / Results of BCG adjuvant immunotherapy for melanoma of the head and neck. In: The American Journal of Surgery. 1976 ; Vol. 132, No. 4. pp. 476-479.
@article{718e989b547a4e23a7bd19211cb6672f,
title = "Results of BCG adjuvant immunotherapy for melanoma of the head and neck",
abstract = "The present study was performed to determine if postoperative systemic BCG adjuvant immunotherapy would improve survival in patients with pathologic stage II melanoma of the head and neck. Seventeen of twenty-five (68 per cent) patients treated with BCG are free of disease, whereas only seven of seventeen (40 per cent) patients treated by radical neck dissection alone are free of disease. Clark's technic for determining the level of invasion of the primary lesion was used to predict the presence of metastatic tumor in regional lymph nodes. Results indicate that patients with pathologically confirmed lymph node metastases from melanoma of the head and neck benefit from postoperative BCG adjuvant immunotherapy.",
author = "Eilber, {Frederick R.} and Courtney Townsend and Morton, {Donald L.}",
year = "1976",
doi = "10.1016/0002-9610(76)90323-8",
language = "English (US)",
volume = "132",
pages = "476--479",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Results of BCG adjuvant immunotherapy for melanoma of the head and neck

AU - Eilber, Frederick R.

AU - Townsend, Courtney

AU - Morton, Donald L.

PY - 1976

Y1 - 1976

N2 - The present study was performed to determine if postoperative systemic BCG adjuvant immunotherapy would improve survival in patients with pathologic stage II melanoma of the head and neck. Seventeen of twenty-five (68 per cent) patients treated with BCG are free of disease, whereas only seven of seventeen (40 per cent) patients treated by radical neck dissection alone are free of disease. Clark's technic for determining the level of invasion of the primary lesion was used to predict the presence of metastatic tumor in regional lymph nodes. Results indicate that patients with pathologically confirmed lymph node metastases from melanoma of the head and neck benefit from postoperative BCG adjuvant immunotherapy.

AB - The present study was performed to determine if postoperative systemic BCG adjuvant immunotherapy would improve survival in patients with pathologic stage II melanoma of the head and neck. Seventeen of twenty-five (68 per cent) patients treated with BCG are free of disease, whereas only seven of seventeen (40 per cent) patients treated by radical neck dissection alone are free of disease. Clark's technic for determining the level of invasion of the primary lesion was used to predict the presence of metastatic tumor in regional lymph nodes. Results indicate that patients with pathologically confirmed lymph node metastases from melanoma of the head and neck benefit from postoperative BCG adjuvant immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0017141485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017141485&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(76)90323-8

DO - 10.1016/0002-9610(76)90323-8

M3 - Article

VL - 132

SP - 476

EP - 479

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -